Oxford Immunotec Global Plc (OXFD) Gross Profit Margin starting from the third quarter 2020 to third quarter 2019, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Oxford Immunotec Global Plc  (NASDAQ: OXFD)


Oxford Immunotec Global Plc's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OXFD Gross Profit Margin (Sep 30 2020)
Q3 		(Jun 30 2020)
Q2 		(Mar 31 2020)
Q1 		(Dec 31 2019)
Q4 		(Sep 30 2019)
Q3
Y / Y Revenue Change -8.4 %
Seq. Revenue Change 233.09 %
Revenue In Millions $19.44
Gross Profit Margin 76.45 %
Gross Profit Margin Total Ranking # 643
Gross Profit In Millions $14.86
Y / Y Gross Profit Change -4.07 %
Seq. Gross Profit Change 305.4 %


Commenting Third Quarter 2020 Gross Profit Margin
Oxford Immunotec Global Plc Gross Profit grew by 305.4 % in Q3 sequentially to 15 millions, while Revenue increased by 233.09 %, this led to improvement in the company's Gross Profit Margin to 76.45 %, above the Oxford Immunotec Global Plc average Gross Profit Margin.


Observing third quarter 2020 results within In Vitro & In Vivo Diagnostic Substances industry 2 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 643, from total ranking in the previous quarter at 1091.
Learn about Gross Margin
OXFD's Gross Profit Margin third quarter 2020 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 3
Healthcare Sector # 136
Overall # 625

Gross Profit Margin Statistics
High Average Low
78.31 % 57.96 % 26.41 %
(Dec 31 2019)   (Dec 31 2018)


OXFD Gross Income Trends • More of OXFD's Profitabilty Ratios • OXFD Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
OXFD's Cumulative Gross Profit Margin
In Vitro & In Vivo Diagnostic Substances Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
OXFD's Gross Profit Margin Profitability versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for OXFD's Competitors
Gross Profit Margin Profit Margin for Oxford Immunotec Global Plc's Suppliers
Gross Profit Margin Profit Margin for OXFD's Customers

You may also want to know
OXFD's Annual Growth Rates OXFD's Profitability Ratios OXFD's Asset Turnover Ratio OXFD's Dividend Growth
OXFD's Roe OXFD's Valuation Ratios OXFD's Financial Strength Ratios OXFD's Gross Profit Growth
OXFD's Roa OXFD's Inventory Turnover Ratio OXFD's Growth Rates OXFD's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2020, within In Vitro & In Vivo Diagnostic Substances Industry Gross Profit MarginSep 30 2020 MRQ Gross ProfitSep 30 2020 MRQ Revenue
Navidea Biopharmaceuticals Inc   99.97 %$ 0.268  Millions$ 0.268  Millions
Quidelortho Corp  80.58 %$ 383.619  Millions$ 476.058  Millions
Oxford Immunotec Global Plc  76.45 %$ 14.858  Millions$ 19.436  Millions
Myriad Genetics Inc   72.52 %$ 105.300  Millions$ 145.200  Millions
Quotient Limited  72.00 %$ 11.567  Millions$ 16.066  Millions
Meridian Bioscience Inc   59.75 %$ 38.331  Millions$ 64.153  Millions
Idexx Laboratories Inc  58.55 %$ 422.606  Millions$ 721.789  Millions
Alpha Teknova Inc   56.63 %$ 5.088  Millions$ 8.984  Millions
Ortho Clinical Diagnostics Holdings Plc  48.10 %$ 217.000  Millions$ 451.100  Millions
Immucell Corporation  46.27 %$ 1.722  Millions$ 3.723  Millions
Neogen Corporation  46.01 %$ 50.302  Millions$ 109.325  Millions
Heska Corporation  41.32 %$ 23.404  Millions$ 56.636  Millions
Lantheus Holdings Inc   40.95 %$ 36.260  Millions$ 88.544  Millions
Aspira Women s Health inc   34.87 %$ 0.432  Millions$ 1.239  Millions
Biomerica Inc   15.99 %$ 0.183  Millions$ 1.144  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.